These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

606 related items for PubMed ID: 30267154

  • 1. What is the diagnostic performance of 18-FDG-PET/MR compared to PET/CT for the N- and M- staging of breast cancer?
    Botsikas D, Bagetakos I, Picarra M, Da Cunha Afonso Barisits AC, Boudabbous S, Montet X, Lam GT, Mainta I, Kalovidouri A, Becker M.
    Eur Radiol; 2019 Apr; 29(4):1787-1798. PubMed ID: 30267154
    [Abstract] [Full Text] [Related]

  • 2. Comparison of Whole-Body (18)F FDG PET/MR Imaging and Whole-Body (18)F FDG PET/CT in Terms of Lesion Detection and Radiation Dose in Patients with Breast Cancer.
    Melsaether AN, Raad RA, Pujara AC, Ponzo FD, Pysarenko KM, Jhaveri K, Babb JS, Sigmund EE, Kim SG, Moy LA.
    Radiology; 2016 Oct; 281(1):193-202. PubMed ID: 27023002
    [Abstract] [Full Text] [Related]

  • 3. Clinical utility of 18F-FDG-PET/MR for preoperative breast cancer staging.
    Botsikas D, Kalovidouri A, Becker M, Copercini M, Djema DA, Bodmer A, Monnier S, Becker CD, Montet X, Delattre BM, Ratib O, Garibotto V, Tabouret-Viaud C.
    Eur Radiol; 2016 Jul; 26(7):2297-307. PubMed ID: 26477029
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Comparison of the diagnostic value of FDG-PET/CT and axillary ultrasound for the detection of lymph node metastases in breast cancer patients.
    Riegger C, Koeninger A, Hartung V, Otterbach F, Kimmig R, Forsting M, Bockisch A, Antoch G, Heusner TA.
    Acta Radiol; 2012 Dec 01; 53(10):1092-8. PubMed ID: 23002144
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Diagnostic performance of 18F-FDG PET/CT, ultrasonography and MRI. Detection of axillary lymph node metastasis in breast cancer patients.
    An YS, Lee DH, Yoon JK, Lee SJ, Kim TH, Kang DK, Kim KS, Jung YS, Yim H.
    Nuklearmedizin; 2014 Dec 01; 53(3):89-94. PubMed ID: 24220324
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Simultaneous whole-body ¹⁸F-FDG PET-MRI in primary staging of breast cancer: a pilot study.
    Taneja S, Jena A, Goel R, Sarin R, Kaul S.
    Eur J Radiol; 2014 Dec 01; 83(12):2231-2239. PubMed ID: 25282709
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Integrated versus separate reading of F-18 FDG-PET/CT and MRI for abdominal malignancies - effect on staging outcomes and diagnostic confidence.
    Min LA, Vogel WV, Lahaye MJ, Maas M, Donswijk ML, Vegt E, Kusters M, Zijlmans HJ, Jóźwiak K, Roberti S, Beets-Tan RGH, Lambregts DMJ.
    Eur Radiol; 2019 Dec 01; 29(12):6900-6910. PubMed ID: 31119418
    [Abstract] [Full Text] [Related]

  • 13. Diagnostic performance of 18F-FDG PET/CT and whole-body diffusion-weighted imaging with background body suppression (DWIBS) in detection of lymph node and bone metastases from pediatric neuroblastoma.
    Ishiguchi H, Ito S, Kato K, Sakurai Y, Kawai H, Fujita N, Abe S, Narita A, Nishio N, Muramatsu H, Takahashi Y, Naganawa S.
    Ann Nucl Med; 2018 Jun 01; 32(5):348-362. PubMed ID: 29667143
    [Abstract] [Full Text] [Related]

  • 14. Diagnostic accuracy of dual-time-point 18F-FDG PET/CT for the detection of axillary lymph node metastases in breast cancer patients.
    Hahn S, Hecktor J, Grabellus F, Hartung V, Pöppel T, Kimmig R, Forsting M, Antoch G, Heusner TA.
    Acta Radiol; 2012 Jun 01; 53(5):518-23. PubMed ID: 22547387
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Comparison of CE-FDG-PET/CT with CE-FDG-PET/MR in the evaluation of osseous metastases in breast cancer patients.
    Catalano OA, Nicolai E, Rosen BR, Luongo A, Catalano M, Iannace C, Guimaraes A, Vangel MG, Mahmood U, Soricelli A, Salvatore M.
    Br J Cancer; 2015 Apr 28; 112(9):1452-60. PubMed ID: 25871331
    [Abstract] [Full Text] [Related]

  • 17. The role of (18)F-FDG PET/CT in initial staging of patients with locally advanced breast carcinoma with an emphasis on M staging.
    Mittal BR, Manohar K, Kashyap R, Bhattacharya A, Singh B, Singh G.
    Hell J Nucl Med; 2011 Apr 28; 14(2):135-9. PubMed ID: 21761015
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Evaluation of PET and MR datasets in integrated 18F-FDG PET/MRI: A comparison of different MR sequences for whole-body restaging of breast cancer patients.
    Grueneisen J, Sawicki LM, Wetter A, Kirchner J, Kinner S, Aktas B, Forsting M, Ruhlmann V, Umutlu L.
    Eur J Radiol; 2017 Apr 28; 89():14-19. PubMed ID: 28267530
    [Abstract] [Full Text] [Related]

  • 20. MRI fused with prone FDG PET/CT improves the primary tumour staging of patients with breast cancer.
    Garcia-Velloso MJ, Ribelles MJ, Rodriguez M, Fernandez-Montero A, Sancho L, Prieto E, Santisteban M, Rodriguez-Spiteri N, Idoate MA, Martinez-Regueira F, Elizalde A, Pina LJ.
    Eur Radiol; 2017 Aug 28; 27(8):3190-3198. PubMed ID: 28004161
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.